{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:55:56Z","timestamp":1793336156212,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025216","name":"Ramsay Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025216","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jad.2025.120192","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:03:58Z","timestamp":1757347438000},"page":"120192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatment"],"prefix":"10.1016","volume":"392","author":[{"given":"Clara","family":"Massaneda-Tuneu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Glozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Vinh","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicollette","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Brettell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Barreiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Karunaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen K.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120192_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2025.120192_bb0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.ajpath.2015.12.014","article-title":"Ketamine-induced apoptosis in normal human urothelial cells: a direct, N-methyl\u2011d-aspartate receptor-independent pathway characterized by mitochondrial stress","volume":"186","author":"Baker","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jad.2025.120192_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116334","article-title":"Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)","volume":"344","author":"Bayes","year":"2025","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","article-title":"The cognitive failures questionnaire (CFQ) and its correlates","volume":"21","author":"Broadbent","year":"1982","journal-title":"Br. J. Clin. Psychol."},{"issue":"7","key":"10.1016\/j.jad.2025.120192_bb0025","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"2","key":"10.1016\/j.jad.2025.120192_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal Esketamine adjunctive to Oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.2018.196","article-title":"Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"214","author":"Domany","year":"2018","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.120192_bb0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/00048674241266057","article-title":"Facilitating routine data collection to improve clinical quality and research in interventional psychiatry: the CARE network","volume":"58","author":"Dong","year":"2024","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120192_bb0045","author":"Farchione"},{"issue":"10","key":"10.1016\/j.jad.2025.120192_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose Esketamine nasal spray combined with a new Oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.120192_bb0055","article-title":"Esketamine treatment for depression in adults: a PRISMA systematic review and meta-analysis","author":"Fountoulakis","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120192_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881118760660","article-title":"Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial","volume":"32","author":"Galvez","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.120192_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","article-title":"Defining remission by cut off score on the MADRS: selecting the optimal value","volume":"72","author":"Hawley","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2025.120192_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1008815005736","article-title":"The assessment of quality of life (AQoL) instrument: a psychometric measure of health-related quality of life","volume":"8","author":"Hawthorne","year":"1999","journal-title":"Qual. Life Res."},{"issue":"9","key":"10.1016\/j.jad.2025.120192_bb0075","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmjqs-2014-002845","article-title":"Between the flags\u2019: implementing a rapid response system at scale","volume":"23","author":"Hughes C","year":"2014","journal-title":"BMJ Qual. Saf."},{"issue":"2","key":"10.1016\/j.jad.2025.120192_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eururo.2011.10.004","article-title":"The bladder pain\/interstitial cystitis symptom score: development, validation, and identification of a cut score","volume":"61","author":"Humphrey","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jad.2025.120192_bb0085","doi-asserted-by":"crossref","unstructured":"Hussain, S., Gale, C., Sarma, S., Smith, J., Bayes, A., & Loo, C. (2025). Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice. Aust. N. Z. J. Psychiatry, 0(0), 1\u201312. doi:https:\/\/doi.org\/10.1177\/00048674251333577.","DOI":"10.1177\/00048674251333577"},{"key":"10.1016\/j.jad.2025.120192_bb0090","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.2017.10","article-title":"Recovering quality of life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties","volume":"212","author":"Keetharuth","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120192_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2018.08.034","article-title":"The lack of meaningful association between depression severity measures and neurocognitive performance","volume":"241","author":"Keilp","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jad.2025.120192_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.jad.2025.120192_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.2023.79","article-title":"Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial","volume":"223","author":"Loo","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCT.0000000000000435","article-title":"The clinical Alliance and research in electroconvulsive therapy network: an Australian initiative for improving service delivery of electroconvulsive therapy","volume":"34","author":"Martin","year":"2018","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2025.120192_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2024.02.052","article-title":"Cognitive outcomes from the randomised, active-controlled ketamine for adult depression study (KADS)","volume":"352","author":"Martin","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2025.120192_bb0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120192_bb0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120192_bb0135","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.4088\/JCP.13m08698","article-title":"Clinical predictors of ketamine response in treatment-resistant major depression","volume":"75","author":"Niciu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120192_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jad.2025.120192_bb0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed Esketamine nasal spray combined with a newly initiated Oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120192_bb0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.genhosppsych.2015.05.009","article-title":"Cut points on the patient health questionnaire (PHQ-9) that predict response to cognitive-behavioral treatments for depression","volume":"37","author":"Schueller","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120192_bb0155","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jad.2020.08.058","article-title":"Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression","volume":"277","author":"Shiroma","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120192_bb0160","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jad.2020.01.120","article-title":"Development of the ketamine side effect tool (KSET)","volume":"266","author":"Short","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.jad.2025.120192_bb0165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04353-w","article-title":"Discrepancy between objective and subjective cognition in adults with major depressive disorder","volume":"7","author":"Srisurapanont","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jad.2025.120192_bb0175","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120192_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00228-023-03605-1","article-title":"A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression","volume":"80","author":"Wang","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.120192_bb0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data Meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120192_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0004867419883341","article-title":"Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials","volume":"54","author":"Witt","year":"2020","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2025.120192_bb0195","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41386-023-01577-5","article-title":"Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study","volume":"48","author":"Zaki","year":"2023","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725016349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725016349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:04:56Z","timestamp":1780203896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725016349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0165032725016349"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120192","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120192"}}